These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30755521)

  • 1. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in
    Campbell NG; Shekar A; Aguilar JI; Peng D; Navratna V; Yang D; Morley AN; Duran AM; Galli G; O'Grady B; Ramachandran R; Sutcliffe JS; Sitte HH; Erreger K; Meiler J; Stockner T; Bellan LM; Matthies HJG; Gouaux E; Mchaourab HS; Galli A
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3853-3862. PubMed ID: 30755521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
    Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
    Elife; 2021 May; 10():. PubMed ID: 34002696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
    Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
    Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.
    Guptaroy B; Zhang M; Bowton E; Binda F; Shi L; Weinstein H; Galli A; Javitch JA; Neubig RR; Gnegy ME
    Mol Pharmacol; 2009 Mar; 75(3):514-24. PubMed ID: 19098122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
    DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
    J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
    Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
    Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.
    Hamilton PJ; Belovich AN; Khelashvili G; Saunders C; Erreger K; Javitch JA; Sitte HH; Weinstein H; Matthies HJG; Galli A
    Nat Chem Biol; 2014 Jul; 10(7):582-589. PubMed ID: 24880859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous dopamine release associated with a human dopamine transporter coding variant.
    Mazei-Robison MS; Bowton E; Holy M; Schmudermaier M; Freissmuth M; Sitte HH; Galli A; Blakely RD
    J Neurosci; 2008 Jul; 28(28):7040-6. PubMed ID: 18614672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacochaperoning in a
    Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
    Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
    Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
    Herborg F; Andreassen TF; Berlin F; Loland CJ; Gether U
    J Biol Chem; 2018 May; 293(19):7250-7262. PubMed ID: 29559554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
    Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
    Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.
    Cheng MH; Bahar I
    Structure; 2015 Nov; 23(11):2171-81. PubMed ID: 26481814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman Spectroscopic Signature Markers of Dopamine-Human Dopamine Transporter Interaction in Living Cells.
    Silwal AP; Yadav R; Sprague JE; Lu HP
    ACS Chem Neurosci; 2017 Jul; 8(7):1510-1518. PubMed ID: 28375605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.
    Midde NM; Huang X; Gomez AM; Booze RM; Zhan CG; Zhu J
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):975-87. PubMed ID: 23645138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Rescue of a Misfolded
    Kasture A; El-Kasaby A; Szöllősi D; Asjad HMM; Grimm A; Stockner T; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2016 Sep; 291(40):20876-20890. PubMed ID: 27481941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT).
    Zwartsen A; Litjens CHC; Hondebrink L; van den Heuvel JJMW; Greupink R; Russel FGM; de Lange DW; Legler J; Koenderink JB; Westerink RHS
    Toxicology; 2019 Jun; 422():69-75. PubMed ID: 31009648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder.
    Hamilton PJ; Shekar A; Belovich AN; Christianson NB; Campbell NG; Sutcliffe JS; Galli A; Matthies HJ; Erreger K
    Mol Autism; 2015; 6():8. PubMed ID: 25741436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization.
    Cheng MH; Garcia-Olivares J; Wasserman S; DiPietro J; Bahar I
    J Biol Chem; 2017 Jul; 292(30):12471-12482. PubMed ID: 28584050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala.
    Mazei-Robison MS; Blakely RD
    Neuropharmacology; 2005 Nov; 49(6):737-49. PubMed ID: 16212992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.